rs34047482

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006231.4(POLE):​c.91G>T​(p.Ala31Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0197 in 1,614,170 control chromosomes in the GnomAD database, including 421 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A31V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 26 hom., cov: 32)
Exomes 𝑓: 0.020 ( 395 hom. )

Consequence

POLE
NM_006231.4 missense

Scores

1
1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:20

Conservation

PhyloP100: 7.41

Publications

14 publications found
Variant links:
Genes affected
POLE (HGNC:9177): (DNA polymerase epsilon, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013]
POLE Gene-Disease associations (from GenCC):
  • POLE-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 12
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • facial dysmorphism-immunodeficiency-livedo-short stature syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • IMAGe syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056500733).
BP6
Variant 12-132681251-C-A is Benign according to our data. Variant chr12-132681251-C-A is described in ClinVar as Benign. ClinVar VariationId is 221182.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0131 (1997/152322) while in subpopulation NFE AF = 0.0211 (1438/68022). AF 95% confidence interval is 0.0202. There are 26 homozygotes in GnomAd4. There are 925 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006231.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
NM_006231.4
MANE Select
c.91G>Tp.Ala31Ser
missense
Exon 2 of 49NP_006222.2Q07864

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLE
ENST00000320574.10
TSL:1 MANE Select
c.91G>Tp.Ala31Ser
missense
Exon 2 of 49ENSP00000322570.5Q07864
POLE
ENST00000535270.5
TSL:1
c.91G>Tp.Ala31Ser
missense
Exon 2 of 48ENSP00000445753.1F5H1D6
POLE
ENST00000537064.5
TSL:1
n.91G>T
non_coding_transcript_exon
Exon 2 of 49ENSP00000442578.1F5H7E4

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1998
AN:
152204
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00453
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0136
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0104
Gnomad FIN
AF:
0.00829
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0211
Gnomad OTH
AF:
0.00956
GnomAD2 exomes
AF:
0.0124
AC:
3113
AN:
251414
AF XY:
0.0129
show subpopulations
Gnomad AFR exome
AF:
0.00338
Gnomad AMR exome
AF:
0.00610
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00748
Gnomad NFE exome
AF:
0.0201
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.0204
AC:
29851
AN:
1461848
Hom.:
395
Cov.:
31
AF XY:
0.0202
AC XY:
14680
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.00332
AC:
111
AN:
33478
American (AMR)
AF:
0.00664
AC:
297
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
38
AN:
26134
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39698
South Asian (SAS)
AF:
0.0102
AC:
882
AN:
86258
European-Finnish (FIN)
AF:
0.00794
AC:
424
AN:
53402
Middle Eastern (MID)
AF:
0.00485
AC:
28
AN:
5768
European-Non Finnish (NFE)
AF:
0.0244
AC:
27129
AN:
1111992
Other (OTH)
AF:
0.0156
AC:
940
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1512
3025
4537
6050
7562
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1034
2068
3102
4136
5170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1997
AN:
152322
Hom.:
26
Cov.:
32
AF XY:
0.0124
AC XY:
925
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00452
AC:
188
AN:
41578
American (AMR)
AF:
0.0136
AC:
208
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.0104
AC:
50
AN:
4826
European-Finnish (FIN)
AF:
0.00829
AC:
88
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0211
AC:
1438
AN:
68022
Other (OTH)
AF:
0.00946
AC:
20
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
110
220
329
439
549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0187
Hom.:
113
Bravo
AF:
0.0134
TwinsUK
AF:
0.0245
AC:
91
ALSPAC
AF:
0.0236
AC:
91
ESP6500AA
AF:
0.00431
AC:
19
ESP6500EA
AF:
0.0220
AC:
189
ExAC
AF:
0.0122
AC:
1485
Asia WGS
AF:
0.00635
AC:
23
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
6
not provided (6)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
2
Colorectal cancer, susceptibility to, 12 (2)
-
-
1
Carcinoma of colon (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
14
DANN
Benign
0.89
DEOGEN2
Benign
0.039
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.23
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.70
T
MetaRNN
Benign
0.0057
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.4
L
PhyloP100
7.4
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
-0.16
N
REVEL
Benign
0.20
Sift
Benign
0.44
T
Sift4G
Benign
0.69
T
Polyphen
0.0040
B
Vest4
0.39
MPC
0.18
ClinPred
0.043
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.047
gMVP
0.37
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34047482; hg19: chr12-133257837; API